Intuitive Surgical (ISRG) to Release Quarterly Earnings on Thursday

Intuitive Surgical (NASDAQ:ISRG) is expected to be announcing its Q4 2025 results after the market closes on Thursday, January 22nd. Analysts expect the company to announce earnings of $2.25 per share and revenue of $2.7238 billion for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, January 22, 2026 at 4:30 PM ET.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.84 earnings per share. On average, analysts expect Intuitive Surgical to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Intuitive Surgical Stock Down 1.4%

NASDAQ:ISRG opened at $527.44 on Wednesday. Intuitive Surgical has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a market cap of $189.08 billion, a P/E ratio of 69.77, a PEG ratio of 4.35 and a beta of 1.67. The business’s 50-day moving average price is $564.60 and its 200 day moving average price is $511.68.

Wall Street Analyst Weigh In

A number of analysts recently commented on ISRG shares. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday. UBS Group restated a “neutral” rating on shares of Intuitive Surgical in a research report on Thursday, January 15th. Citigroup cut Intuitive Surgical from a “buy” rating to a “neutral” rating and dropped their price target for the company from $650.00 to $635.00 in a report on Thursday, December 11th. Barclays reissued an “overweight” rating and set a $686.00 price objective (up from $635.00) on shares of Intuitive Surgical in a research note on Wednesday, January 7th. Finally, Raymond James Financial set a $603.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $622.17.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 7,562 shares of Intuitive Surgical stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the sale, the executive vice president owned 353 shares of the company’s stock, valued at $193,595.79. This trade represents a 95.54% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Mark Brosius sold 4,500 shares of the business’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the transaction, the senior vice president owned 907 shares in the company, valued at approximately $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 114,007 shares of company stock worth $63,533,844 over the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Institutional Trading of Intuitive Surgical

Institutional investors have recently bought and sold shares of the company. Brighton Jones LLC lifted its holdings in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the last quarter. Sivia Capital Partners LLC raised its position in shares of Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after purchasing an additional 34 shares during the period. Schnieders Capital Management LLC. lifted its stake in shares of Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after buying an additional 268 shares during the last quarter. Florida Financial Advisors LLC acquired a new stake in shares of Intuitive Surgical in the second quarter worth $272,000. Finally, SIH Partners LLLP bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth $277,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.